Yves Moreau

Yves Moreau is a professor at KU Leuven ESAT STADIUS, where his team develops AI algorithms and platforms for integrating complex data in clinical genomics and drug discovery: federated analysis of clinical and genomic data, identification of pathogenic genetic variation in rare disorders and liquid biopsies, and data fusion for drug design. He works on deep learning and Bayesian matrix factorization for fusing heterogeneous, sparsely observed data, and on privacy-preserving implementations, always with an eye on clinical and industrial applicability. He also reflects publicly on how AI is reshaping society and actively pushes back against the emergence of surveillance societies. As a tech innovator, he co-founded Data4S, a fraud detection and anti-money laundering company now part of BAE Systems Detica NetReveal, and Cartagenia, specialised in clinical genetic diagnosis and since acquired by Agilent Technologies.